Mirae Asset Global Investments Co., Ltd. Lyell Immunopharma, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 9,776 shares of LYEL stock, worth $4,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,776
Previous 9,305
5.06%
Holding current value
$4,008
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$8.27 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$6.56 Million9.84% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.19 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.19 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.53 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $102M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...